Amblyopia management: A new paradigm

Video
Conference|SECO

Robert Sanet, OD, explains the new paradigm in amblyopia, or lazy eye, management

During SECO 2022, Robert Sanet, OD, co-director of Sanet Vegara Vision Seminar, based in San Diego, discussed the SECO 2022 lecture he’s presenting along with Pilar Vergara, OD titled “A new paradigm for amblyopia management”.

Recent Videos
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
Related Content
Conference audience Image credit: AdobeStock/John

Top takeaways from the 2024 meeting of the American Academy of Optometry

Emily Kaiser Maharjan, Assistant Managing Editor
December 16th 2024
Article
Practical management EP 14: Your practice-purchase checklist

Practical management EP 14: Your practice-purchase checklist

Maria Sampalis, OD;Kassi Jackson Filkins, Editor
April 27th 2023
Podcast
Medical profession in PPE in front of AI graphic Image credit: AdobeStock/ipopba

How artificial intelligence is impacting optometry

Vittorio Mena, OD, MS,
November 26th 2024
Article
Jill Saxon, OD, executive director of professional strategy at Bausch + Lomb

Community care: Connecting mentorship and representation

Emily Kaiser Maharjan, Assistant Managing Editor
April 26th 2023
Podcast
A table mid-discussion at the Merton C Flom Leadership Academy luncheon. Image credit: CooperVision.

AAOpt 2024: Merton C Flom Leadership Academy luncheon provides insights and takeaways on the program

Jordana Joy, Associate Editor
November 13th 2024
Article
MediPrint Ophthalmic presented positive topline results from phase 2b study of drug-eluting contact lens - ©Andrey Popov

MediPrint Ophthalmics reveals positive results from phase 2b study of LL-BMT1 contact lens

Martin David Harp, Associate Editor, Ophthalmology Times
November 12th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.